Neutropenia differential diagnosis

Jump to navigation Jump to search

Neutropenia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neutropenia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neutropenia differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neutropenia differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neutropenia differential diagnosis

on Neutropenia differential diagnosis

Neutropenia differential diagnosis in the news

Blogs on Neutropenia differential diagnosis

Directions to Hospitals Treating Neutropenia

Risk calculators and risk factors for Neutropenia differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Daniel A. Gerber, M.D. [2]

Overview

Neutropenia is diagnosed on a complete blood count differential and the severity is classified based on neutrophil count. Neutropenia is diagnosed when the absolute neutrophil count (ANC) is less than 1500 cells/µL.

Differential Diagnosis

Neutropenia is a laboratory diagnosis based off of the complete blood count differential, however the differential diagnosis for the etiology of neutropenia is quite important in diagnosing and treating these patients.

Consider the following broad differential when evaluating a patient with neutropenia:

  • Congenital neutropenia: rare, inherited mutations in the genes ELA2 or HAX1.[1]
  • Cyclic neutropenia: 3 week cycles of neutropenia due to changing rates of neutrophil production by the bone marrow. Also the result of hereditary ELA2 mutations.[2]
  • Idiopathic neutropenia
  • Myelokathexis: rare, inherited mutations in CXCR4 result in warts, hypogammaglobulinemia, and recurrent infections.[3]
  • Autoimmune neutropenia: antibody-mediated neutrophil destruction.
  • Drug-induced neutropenia: 75% of all cases of agranulocytosis in the United States.

References

  1. Welte K, Zeidler C, Dale DC (2006). "Severe congenital neutropenia". Semin Hematol. 43 (3): 189–95. Text "pmid 16822461" ignored (help)
  2. Bellanné-Chantelot C; et al. (2004). "Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register". Blood. 103 (11): 4119–25. PMID 14962902.
  3. Aprikyan AA, Liles WC, Park JR, Jonas M, Chi EY, Dale DC. (2000). "Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors". Blood. 95 (1): 320–7. PMID 10607719.

Template:WH Template:WS